Xcout Intel
Resistell
Headquartered in Muttenz, Switzerland, Resistell AG is a biotechnology company incorporated in 2018 that develops rapid antibiotic susceptibility testing devices as an innovative alternative to traditional culture-based antibiograms.
Subscribe to see Resistell’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Resistell at a glance
Resistell is a biotechnology company headquartered in Switzerland. Its most recent funding round, Series B, raised $9.1M in December 2022. Xcout tracks 25 named people at Resistell, including Grzegorz Gonciarz (COO).
Resistell leadership
- Grzegorz GonciarzCOO
- Martin BirkCFO
- Dr. Alex SturmChief Scientific Officer
- Dr. Danuta CichockaCEO, Co-Founder, Board Member
- Dr. Sandor KasasInventor, Co-Founder
- Prof. Giovanni DietlerInventor, Co-Founder
19 more named people on record for Resistell, with roles, board committees and tenure — see the full roster →
Resistell funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $9.1M | 6 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Resistell competitors
A few of Resistell's closest competitors — see the full list of competitors and alternatives →
Sysmex Astrego is a medical technology company specializing in automated antibiotic susceptibility testing to combat antimicrobial resistance.
Affinity Biosensors manufactures the LifeScale system, a medical technology product that provides rapid antimicrobial susceptibility testing (AST) results for gram-negative bacteria from positive blood cultures. The system uses population-profiling technology to deliver laboratory test results in approximately four hours to assist medical and laboratory professionals.
BIOPIX-T is a certified medical technology company based in Heraklion, Crete, Greece, that specializes in the design, development, and production of molecular diagnostic platforms like PEBBLE qcLAMP.
Royal Biotech Inc. develops, manufactures, and markets portable diagnostic analysis products, handheld systems, and test kits for clinical, veterinary, food safety, and environmental applications. The company serves public security and health sectors by providing molecular and microfluidic diagnostic devices designed for on-site use.
Magnolia Medical Technologies, Inc. is a medical device company headquartered in Seattle and Bellevue, Washington. The company develops diagnostic and blood collection technologies designed to reduce in-vitro diagnostic errors and improve blood culture accuracy.
iFAST Diagnostics is a United Kingdom-based diagnostics company developing low-cost, high-throughput rapid antimicrobial susceptibility testing (AST) technology. The firm focuses on combating antimicrobial resistance globally with a team of 11 to 50 employees.
Get Resistell's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Resistell in Xcout Intel
- 25 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access